Evidence map›Paper›PMID 29980624›Full record

ArticleThe Journal of cell biology2018

Genome-edited human stem cells expressing fluorescently labeled endocytic markers allow quantitative analysis of clathrin-mediated endocytosis during differentiation.

Daphné Dambournet, Kem A Sochacki, Aaron T Cheng, Matthew Akamatsu, Justin W Taraska, Dirk Hockemeyer, David G Drubin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Profile of David G. Drubin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Review
  11. Generation of nanoscopic membrane curvature for membrane trafficking.Nature reviews. Molecular cell biology · 2023
    Review
  12. B cell receptor (BCR) endocytosis.Progress in molecular biology and translational science · 2023
    Review
  13. Human epiblast lumenogenesis: From a cell aggregate to a lumenal cyst.Seminars in cell & developmental biology · 2022
    Review
  14. Article
  15. Article
  16. Load adaptation by endocytic actin networks.Molecular biology of the cell · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Daphné DambournetDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.
Kem A SochackiNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Aaron T ChengGlaxoSmithKline, Collegeville, PA.
Matthew AkamatsuDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.ORCID 0000-0002-0286-5310
Justin W TaraskaNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0001-5355-9535
Dirk HockemeyerDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA.ORCID 0000-0002-5598-5092
David G DrubinDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA drubin@berkeley.edu.ORCID 0000-0003-3002-6271
University of California, Berkeley · USNational Institutes of Health · USGlaxoSmithKline (United States) · US

Funding

Architecture and control of vesicle fusion in excitable cellsZIAHL006098 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI TARASKA, JUSTIN · 2011 to 2025
$25.5M
Nikon confocal system for improved spatio-dynamic analysis of endocytic trafficking eventsR35GM118149 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI DAVID G DRUBIN · 2016 to 2026
$12.0M
Telomerase function in human tumor and stem cell biologyR01CA196884 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI HOCKEMEYER, DIRK · 2015 to 2019
$1.7M
NCI NIH HHS R01 CA196884NIGMS NIH HHS R35 GM118149
6 · The paper itself

Abstract

We developed a general approach for investigation of how cellular processes become adapted for specific cell types during differentiation. Previous studies reported substantial differences in the morphology and dynamics of clathrin-mediated endocytosis (CME) sites. However, associating specific CME properties with distinct differentiated cell types and determining how these properties are developmentally specified during differentiation have been elusive. Using genome-edited human embryonic stem cells, and isogenic fibroblasts and neuronal progenitor cells derived from them, we established by live-cell imaging and platinum replica transmission electron microscopy that CME site dynamics and ultrastructure on the plasma membrane are precisely reprogrammed during differentiation. Expression levels for the endocytic adaptor protein AP2μ2 were found to underlie dramatic changes in CME dynamics and structure. Additionally, CME dependency on actin assembly and phosphoinositide-3 kinase activity are distinct for each cell type. Collectively, our results demonstrate that key CME properties are reprogrammed during differentiation at least in part through AP2μ2 expression regulation.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsCell DifferentiationCell LineClathrinEmbryonic Stem CellsEndocytosisFibroblastsGene EditingGene Expression Regulation, DevelopmentalHumansMiceMicroscopy, Electron, TransmissionNeural Stem CellsPhosphatidylinositol 3-KinaseAdaptor Proteins, Vesicular TransportClathrinendocytic adaptor protein 2mu, mousePhosphatidylinositol 3-Kinase

Identifiers

PMID29980624
PMCPMC6123002
OpenAlexW2876021654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.